Company / R&D per Share
Alkermes plc R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.96
FY2025
5-year range
$1.51 / $1.96
FY2021-FY2025
Trend
+29.3%
vs FY2024
Sector context
#105 of 208
Health Care
What the data says
At $1.96, Alkermes plc's r&d per share ranks #105 of 208 in the Health Care sector. R&D per Share returned to growth in FY2025 after 5 years of decline, reaching $1.96.
Based on SEC 10-K filings.
1.96 in FY2025 with a 5-year CAGR of -4.6%.
Improved from $1.62 to $1.96 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +5.6%
- 5-Year CAGR
- -4.6%
- 10-Year CAGR
- -
Sector benchmark
#105 of 208 in Health CareTop 50% of 208This company $1.96 Sector average $28.82
▼
-93.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 29.3% year-over-year.
- Ranks #105 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2024.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.96 | +29.3% |
| FY2024 | $1.51 | -6.7% |
| FY2023 | $1.62 | -2.2% |
| FY2022 | $1.66 | -7.7% |
| FY2021 | $1.80 | -27.5% |
| FY2020 | $2.48 | -23.7% |
| FY2019 | $3.25 | +19.0% |
| FY2018 | $2.73 | +1.9% |
| FY2017 | $2.68 | +4.4% |
| FY2016 | $2.57 | +195.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026